India were playing a warm up game against Leicestershire last week when the news of the Hitman came that he has tested positive. Now, the latest issue which is a big concern is that who will lead India in absence of Rohit Sharma and moreover, vice-captain KL Rahul is also ruled out of the series due to an injury.

“We’ll keep monitoring him (Sharma). We’ve got close to 36 hours to go. he’ll have a test later tonight and one tomorrow as well. It’s up to the medical team to decide. We haven’t had a chance to see him as he’s in quarantine.” Dravid told the reporters.

A strong buzz is that pacer Jasprit Bumrah will be leading if Rohit doesn’t recover on time, although nothing has been finalized yet. The playing XI will also suffer in absence of the captain, Mayank Agarwal has been brought up as replacement for Rohit Sharma.

Former Indian skipper Virat Kohli has been a question of concern as well due to his inconsistent form. King Kohli last hit an international ton almost three years ago. However, coach Dravid is satisfied by the 33 year old’s progress in the past few days.

The post Will Rohit Sharma make it to the 5th Test match? appeared first on The Tech Outlook.

Russia accused the US of experimenting with ‘bat coronavirus samples’ and developing biological weapons in Ukraine, but provided no evidence, as Moscow attempted to justify its brutal invasion.

The Kremlin’s accusation comes after the White House warned yesterday that Russian President Vladimir Putin could use chemical or biological weapons in the country and that such accusations were being used as a “false flag” to justify their use.

In a televised briefing, Russian defence ministry spokesman Igor Konashenkov stated that “the purpose of this – and other Pentagon-funded biological research in Ukraine – was to establish a mechanism for the stealthy spread of deadly pathogens.”

According to Konashenkov, the ministry obtained documents detailing US military-biological activities in Ukraine, including the movement of Ukrainians’ biomaterial abroad.

Washington, he said, ‘planned to conduct research on bird, bat, and reptile pathogens, as well as African swine fever and anthrax.’

‘Biolaboratories established and funded in Ukraine have been experimenting with bat coronavirus samples,’ Konashenkov added, again without elaborating.

Both Washington and Kiev have denied the existence of biological weapons laboratories in the country, which has been under Russian attack by tens of thousands of troops since February 24.

In 2018, Russia accused the US of secretly conducting biological experiments in a lab in Georgia, another former Soviet republic that, like Ukraine, aspires to join NATO and the European Union. This was widely disproved.

Jen Psaki called Russia’s claims that the U.S. is building bioweapon labs in Ukraine as ‘preposterous propaganda’. Russia has a history of gaslighting with its accusations against the West, and her comments were part of an ‘obvious ploy’ for Putin to continue bombing Ukraine. Russia has accused the US of having a network of bio-labs in Ukraine. The US has denied having such a network. Russia has a track record of accusing the West of the very violations that Russia itself is perpetrating – chemical and biological weapons against its enemies.

The post Russia accuses US of ‘experimenting with bat coronavirus samples’ in Ukraine appeared first on The Tech Outlook.

In November previous year, the corporation obtained a decree to provide 1 crore Vaccine Dose to Ahmedabad.

The organization is moreover planning to formulate Zyvox-D available in the private demand. This vaccine will be rated at Rs 265 per dose and the applicator will be delivered at Rs 93 per dose eliminating GST.

ZyCoV-D is a three-dose intra skin vaccine utilizing The PharmaJet needle unrestricted strategy with first dose, second dose on Day 28 and third one on Day 56, with each dose encompassing on both arms.

PharmaJet is a needle-free applicator that assures painless intradermal vaccine release and avoids any sort of crucial side consequences. The vaccine can be bottled 2-8 degrees Celsius for extended usage.

ZyCoV-D’s DNA Plasmid strategy enables producing recent constructs rapidly to market with transformations in the virus.

The thermostability of the vaccine will enable in simple carrier and storage of the vaccine without any climate variation problems.

The post Zydus has commenced supplying its DNA Plasmid-based coronavirus vaccine appeared first on The Tech Outlook.

The chart of Coronavirus infection begins again to boost in India. In the last 24 hours, 33,379 recent patients have been found in the nation. There occurred 124 demises during this period. Encompassing the new charts, the number of patients in the nation has attained 3 crore 49 lakh 60 thousand 261.

At the similar time, 4 lakh 82 thousand 17 patients have forfeited their lives due to virus so far. At present, medication of 1 lakh 71 thousand 830 infected is going on in the nation. The fortunate information is that till now 3 crore 43 lakh 6 thousand 414 people have returned residence after being effective.

In Maharashtra

On Monday, 12,160 fresh cases of corona virus infection was recounted in Maharashtra while 11 people deceased. The number of patients under therapy in the province has crossed 50 thousand. The Health Department gave this information.

The department announced in a publication that after the appearance of new cases, the number of infected in the state has increased to 67,12,028 while the death toll has gone up to 1,41,553. It has been said that 68 new cases of Omicron have been reported in the state, after which the number of Omicron infected patients in the state has gone up to 578.

In Kerala

On Monday, 2,560 fresh cases of Covid-19 were recorded in Kerala and 71 patients deceased, taking the full cases of virus to 52,45,849 and the death loss to 48,184. Out of the 71 patients who died, 30 died in the last few days and 41 deaths have been expanded to the cases of death due to Covid-19 after obtaining a plea on the directions of the Center and the Supreme Court.

Arvind Kejriwal

Let’s tell you that CM Arvind Kejriwal also Gets positive with Covid 19 Infection.

https://www.thetechoutlook.com/internet/politics/arvind-kejriwal-tests-covid-positive-says-mild-symptoms/

The Union Health Ministry announced that till 8 pm on the early day of the vaccination theme in the 15 to 18 age group on Monday, more than 41 lakh adolescents took the first dose of the anti-Kovid-19 vaccine.

The post 33,379 new corona patients found in 24 hours, Omicron cases increased to 1,892 appeared first on The Tech Outlook.

https://www.thetechoutlook.com/internet/nation/pm-narendra-modi-announces-vaccination-for-15-18-years-age-group/

Registration began on CoWIN portal

Union Health Minister Dr Mansukh Mandaviya has tweeted that Children are safe, the fate of the country is protected. On the event of New Year, enrollment is being commenced on COWIN portal for vaccination of teenagers in the age group of 15 to 18 years.  

3.15 lakh children enrolled so far. According to CoWIN data, till 11.30 pm on Saturday night, 3,15,416 teenagers of 15-18 years have enrolled, who will begin getting vaccination from tomorrow.

Children will receive only the dose of ‘Covaxin’ The Union Health Secretary has notified all the States and Union Territories that teenagers in the age group of 15-18 will be given only the dosage of ‘Covaxin’ at present made by Bharat Biotech Company.

You can also, enrol quickly by visiting the vaccination centre but to ensure social distancing and availability of doses at the centre it is prefer to register on CoWIN Portal. All vaccinated children will have to register themselves on the Co-WIN portal from January 1, 2022. From January 3, 2022, you can furthermore enrol immediately by attending the vaccination camp.

The second dose of vaccine will be given only after 28 days Bharat Biotech’s Covaxin will be allocated to children and there will be an extent of only 28 days between two doses. However, the second dose of Covaxin is furthermore being given to adults only after 28 days.

To generate a vaccine slot for teenagers of 15-18 year’s old, first enroll on the Co-WIN app. You have to login with your mobile number. A original photo certificate of the youngster will also be compelled to generate the vaccine slot. If young teenagers do not have certificates like Voter ID, then Aadhar card will be used.

To read more about the process visit this link https://www.thetechoutlook.com/news/covid19-vaccination-children-can-register-on-cowin-app-from-1-january/

The post Children of 15-18 year olds will be vaccinated from tomorrow, above 3.15 lakh registered till now appeared first on The Tech Outlook.

Researchers all around the globe are working hard to find out the answers to their questions about the deadly variant but one thing that we know is that its mild symptoms can cause dangerous consequences which are why people should be aware of it. But to protect yourself and your family you must know what the variant’s effects look like, so here are the symptoms which are the harbingers to ask you to get alert.

• The basic symptoms of COVID included fever or chills, cough, runny nose, headache or muscle aches and they also appear in the new variant infections but are way milder.
• If you feel issues like congestion, sore or scratchy throat and your body aches really bad, then you must get checked. The Omicron patients feel a lot tired and their body lacks energy which can be due to various reasons but it’s an alert sign during this time.
• A very mild loss of taste and smell has been noticed in people infected with the Omicron Virus. They are sometimes neglected by people but ignoring these basic symptoms can make you regret that a lot. So get checked if you feel any of it.
• Vomiting or nausea are common symptoms. Moreover, it is a respiratory disease so if you ever feel shortness of breath anytime, it’s very dangerous.

According to the current estimates, unvaccinated people are nine times more prone to severe illness than vaccinated ones. So getting vaccinated and boosted is necessary for the current scenario. With corona evolving the people also need to evolve. Be a little vigilant, if you notice even a single mild symptom don’t neglect it and get tested.

And even if you are vaccinated, get a booster but still stay alert.

Mask Up and let’s begin the must-win battle against this new Variant of COVID-19, Omicron.

The post What are the Common Symptoms of Omicron Variant of Coronavirus? Check it Out! appeared first on The Tech Outlook.

The variant is very hazardous as it performs to invade the immune protections generated by vaccines or natural COVID-19 infections and make the body miserable. So now the National Institute of Allergy and Infectious Diseases (NIAID) has collaborated with Moderna Inc. to test a new kind of weapon named booster which will trigger the immune system of the body to recognize and attack the variant. The trial phase 1 will be done in 210 adults to make sure that it is safe and effective.

Moderna said about the booster, “A booster dose of an authorized vaccine represents the only currently available strategy for boosting waning immunity.”

The director of the vaccine research center at the NIAID, John Mascola has opened up about the trials, “The mutations are just in the right place on the surface of the viral protein and cause some antibodies to not ‘see’ that protein.” He added, “These studies are being conducted to answer the question of whether a booster vaccine will induce a broader immune response.”

Pfizer and BioNTech have asked the authorities to provide more information about the variants so that they can develop effective vaccines in a short period of time. The new vaccine and booster would be totally different as it will deliver the instructions for producing a spike protein instead of providing instructions for making the spike protein that was present on the original strain of SARS-CoV-2.

The post Is booster dose required for South African B.1.351 Variant? Check it out! appeared first on The Tech Outlook.

Even as other nations cautiously lift restrictions, Beijing has maintained a persistent zero-Covid strategy with tight border closures and targeted lockdowns.

Domestic outbreaks have mostly been eradicated, but China’s coronavirus restrictions have been tightened after the sixth day of new cases, primarily in the north and northwest.

The most recent epidemic was traced back to an elderly couple who were part of a group of visitors. They began their journey in Shanghai, then flew to Xi’an, Gansu Province, and Inner Mongolia.

Since then, dozens of cases have been connected to their trip, including close ties in at least five provinces and regions, including Beijing.

Local governments have responded by conducting mass testing, closing scenic locations and tourist attractions, schools, and entertainment venues in impacted regions, and enforcing targeted lockdowns of housing compounds.

Residents in several areas, notably Lanzhou, a four-million-person metropolis in northern China, have been advised not to leave unless absolutely essential.

Those who need to depart must produce a Covid-19 test that is negative.

According to statistics from aviation tracker VariFlight, hundreds of flights have been canceled at airports in the impacted areas.

Around 60% of flights to and from Xi’an and Lanzhou’s major airports have been canceled.

Erenhot in Inner Mongolia issued a notice on Monday prohibiting people from leaving their housing compounds and prohibiting movement in and out of the city.

The state-owned tabloid Global Times warned on Wednesday that the new viral cases in Inner Mongolia were likely to have an impact on Mongolian coal imports due to supply chain delays.

According to China’s National Health Commission, 13 additional domestic cases were recorded on Thursday.

The post Covid Outbreak : As China battles a coronavirus outbreak, flights have been cancelled and schools have been halted appeared first on The Tech Outlook.

How Corbevax functions

Corbevax is a “recombinant protein sub-unit” immunization, which implies it is comprised of a particular piece of SARS-CoV-2 — the spike protein on the infection’s surface.

The spike protein permits the infection to enter the cells in the body so it can imitate and cause illness. In any case, when this protein alone is given to the body, it isn’t required to be destructive as the remainder of the infection is missing. The body is required to foster an insusceptible reaction against the infused spike protein. Subsequently, when the genuine infection endeavors to contaminate the body, it will as of now have an invulnerable reaction prepared that will make it far-fetched for the individual to fall seriously sick.

Albeit this innovation has been utilized for quite a long time to make hepatitis B immunizations, Corbevax will be among the principal Covid-19 antibodies to utilize this stage. Novavax has additionally fostered a protein-based immunization, which is as yet hanging tight for crisis use authorization from different controllers.

How Corbevax was made

While it is natively created, Corbevax’s beginnings can be followed to the Baylor College of Medicine’s National School of Tropical Medicine. The School had been dealing with recombinant protein antibodies for Covids SARS and MERS for 10 years.

“We realized every one of the procedures needed to create a recombinant protein (immunization) for Covids at significant degrees of productivity and uprightness,” said Dr. Peter Hotez, Professor and Dean at the School.

At the point when the hereditary succession for SARS-CoV-2 was made accessible in February 2020, specialists at the School pulled out the grouping for the quality of the spike protein, and dealt with cloning and designing it. The quality was then placed into yeast, so it could make and deliver duplicates of the protein. “It’s really like the creation of lager. Rather than delivering liquor, for this situation, the yeast is delivering the recombinant protein,” Dr. Hotez said.

After this, the protein was sanitized to eliminate any reminders of the yeast “to make it unblemished”. At that point, the antibody was planned to utilize an adjuvant to all the more likely animate the invulnerable reaction.

The greater part of these fixings is modest and simple to discover.

In August, BCM moved its creation cell bank for this antibody to Biological E, so the Hyderabad-based organization could take the applicant through preliminaries. The immunization has gotten endorsement for stage 3 preliminaries, which the public authority expects will be over by July.

Natural E is additionally expected to increase creation for the world.

How Corbevax is extraordinary

Other Covid-19 antibodies endorsed so far are either mRNA immunizations (Pfizer and Moderna), viral vector immunizations (AstraZeneca-Oxford/Covishield, Johnson and Johnson, and Sputnik V), or inactivated immunizations (Covaxin, Sinovac-CoronaVac and Sinopharm’s SARS-CoV-2 Vaccine–Vero Cell).

Inactivated antibodies, which incorporate murdered particles of the entire SARS-CoV-2 infection, endeavor to focus on the whole construction of the infection. Then again, Corbevax, similar to the mRNA and viral vector Covid-19 antibodies, targets just the spike protein, yet in an alternate way.

Viral vector and mRNA and immunizations utilize a code to initiate our cells to make the spike proteins against which the body needs to construct resistance. “For this situation (Corbevax), we’re really giving the protein,” said Dr. Hotez.

Like most other Covid-19 immunizations, Corbevax is regulated in two dosages. Nonetheless, as it is made utilizing a minimal expense stage, it is additionally expected to be among the least expensive accessible in the country.

Why Corbevax matters

This is the first run through which the Indian government has put in a request for an immunization that has not gotten crisis use authorization, paying Rs 1,500 crore ahead of time to hinder a request that could inoculate 15 crore, Indian residents. The Center has given major pre-clinical and clinical preliminary help towards the immunization’s turn of events, remembering an award for the help of Rs 100 crore from the Department of Biotechnology.

A significant justification India putting in a major request is the challenges it is looking at in upgrading immunization supplies. While the US, UK, and the EU had made settlements ahead of time and in danger interests into antibodies like Pfizer, AstraZeneca, and Moderna, India held up until after its initial two immunizations were endorsed prior to submitting restricted requests. Even after the public authority facilitated administrative prerequisites for unfamiliar immunizations, it didn’t get a rapid reaction from organizations like Pfizer and Moderna, their provisions previously impeded through orders from different nations. India is presently in dealings for a restricted stockpile of Pfizer’s antibody, and hoping to get up to two billion dosages of Covid immunizations by December this year. Given the straightforwardness with which it very well may be mass-created, Corbevax could make up a sizeable bit of this normal stockpile.

Organic E, the maker of Corbevax

Organic E, settled in Hyderabad, was established by Dr. D V K Raju in 1953 as a natural items organization that spearheaded the creation of heparin in India. By 1962, it forayed into the immunization space, creating DPT antibodies for an enormous scope. Today, it is among the significant immunization creators in India and, by its own case, the “biggest” lockjaw antibody maker on the planet.

It has seven WHO-prequalified shots, remembering a five-for-one antibody against diphtheria, lockjaw, pertussis, hepatitis B, and Haemophilus flu-type-b diseases. Its immunizations are provided to more than 100 nations and it has provided in excess of two billion portions over the most recent 10 years alone.

Since 2013, the organization has been under the administration of Mahima Datla — the third era of the establishing family. During her time as overseeing chief, the organization has gotten WHO prequalification of its Japanese encephalitis, DTwP, and Td just as measles and rubella immunizations and furthermore initiated business activities in the US.

The post Is Corbevax an answer to India’s growing COVID-19 vaccine demand; details inside appeared first on The Tech Outlook.

Researchers have ranked the pandemic responses of 180 countries on a ‘stringency map’ by looking at how Covid restrictions have affected schools, offices, social gatherings, international travel and freedom to leave home, reports the Daily Mail UK.

Each country was scored on a scale of one to 100, with a higher figure indicating the most severe virus-controlling curbs. The numbers represented an average since the start of the pandemic.

This map shows how lockdown rules differed between countries on February 17

+ The harshest rules are indicated by pink and red

Read more: https://t.co/2rQypWg5vQ pic.twitter.com/ykaahXMyVT

— Mail+ (@DailyMailUK) February 23, 2021

The team put Britain’s Covid restrictions at 86.11 out of 100 by February 17, using the latest available data. Britain’s lockdown was ranked harsher than France (63.89) and the US (68.06), and stricter than Germany’s (83.33).

The analysis comes after Prime Minister Boris Johnson’s new lockdown exit strategy. This strategy can see England resuming normal operations during June. The PM’s plan for easing restrictions will be split into four separate steps and will see the country treated as a whole, with no return to a tier system.

Under the first stage, schools in England will reopen from March 8 — though the next stage of loosening won’t be until March 29, when the formal Stay at Home edict is finally dropped. Shops, hairdressers and pubs must remain closed until April 12 at the earliest and international travel is completely off the cards until at least May 17.

Only on June 21 will all legal limits on social contact go, and the remaining elements of the hospitality sector be allowed to open. The Prime Minister stressed that he is being driven by ‘data not dates’ and the timeline is not guaranteed.

The UK is in total lockdown with people only allowed to leave their homes for essential shopping, medical visits or work that can’t be done from home. International travel and socialising in person are banned, and most shops are closed.

The post Is Britain’s lockdown the toughest in the world? appeared first on The Tech Outlook.